Navigation Links
TRPM7 protein key to breast cancer metastasis in animal models
Date:8/7/2012

PHILADELPHIA The protein transient receptor potential melastatin-like 7 (TRPM7) is a critical determinant of breast cancer cell metastasis, according to study results published in Cancer Research, a journal of the American Association for Cancer Research.

"The most important discovery that we report in this paper is that TRPM7 is required for metastasis, at least in a xenograft model of breast cancer metastasis," said Frank van Leeuwen, Ph.D., assistant professor at the Radbound University Medical Center in Nijmegen, the Netherlands. "While this fundamental biological finding will not have an immediate impact on patient care, we believe that it opens the door to a previously under-explored area of cancer therapeutics.

"TRPM7 functions as a cation channel. As such, it is in a class of proteins that is already therapeutically targeted to treat diseases; for example, cation channel blockers are used to treat several heart conditions. Given that cation channels are druggable, our data provide clear rationale for probing whether drugs that target this class of proteins could block metastasis."

Central to tumor metastasis are changes in the capacity of tumor cells to adhere to other cells and tissue at the original tumor site and changes in their ability to migrate. As TRPM7 was known to be involved in regulating cell adhesion and migration, van Leeuwen and his colleagues, including researchers at The Netherlands Cancer Institute in Amsterdam, set out to investigate whether TRMP7 had a role in cancer cell metastasis.

They evaluated whether the level of expression of the TRPM7 gene correlated with breast cancer progression. In primary breast tumors removed at diagnosis from a cohort of 368 women, high levels of expression from the TRPM7 gene were associated with significantly shorter times to both recurrence of disease and occurrence of distant metastases. This association was validated in an independent cohort of 144 bre
'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Vanderbilt researchers find proteins may point way to new prostate cancer drug targets
2. UNC team describes novel inflammatory protein function
3. In Mice, Alzheimers-Linked Protein Shows Promise Against MS
4. Protein-based coating could help rehabilitate long-term brain function
5. SFU duos protein discovery links to cancer research
6. Protein build-up leads to neurons misfiring
7. Strong communication between brain and muscle requires both having the protein LRP4
8. Regulation by proteins outside cancer cells points to potential new drug target
9. Loss of protein SPDEF allows prostate cancer cells to gain foothold at possible sites of metastasis
10. The key (proteins) to self-renewing skin
11. Researchers discover rare leukemia-causing protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... ... launch of their new website, the Invokana Ketoacidosis Lawsuit Center . The ... serves as a resource for persons wishing to learn more about Invokana lawsuits ...
(Date:7/7/2015)... ... July 07, 2015 , ... CareSync proudly announces ... recognized by the White House as a “Champion of Change” for Precision Medicine ... Initiative, the Champions of Change program recognizes Gleason and eight other extraordinary individuals ...
(Date:7/6/2015)... ... July 07, 2015 , ... Currently, mobile testing ... of AIDS, advances in the molecular diagnostic technologies, wide availability of immunosuppressive drugs ... detection technologies and genetic engineering also open lucrative opportunities for the market players. ...
(Date:7/6/2015)... ... ... TapGlance ” was featured on NewsWatch as part of its monthly AppWatch, which takes ... and Windows. Joe Toohey, the host of AppWatch and technology expert, conducted the app ... rooms will look like before they even start renovating.. , Whether a person is ...
(Date:7/6/2015)... ... 2015 , ... Shortly after opening her second practice in Signal Hill, Dr. ... on a lien basis. Dr. Lim had previously worked with Dr. Kevin Kelly, ... refugees, Dr. Lim suffered with back pain herself throughout high school. Unaware of ...
Breaking Medicine News(10 mins):Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 2Health News:White House names Champions of Change for Precision Medicine: CareSync COO Recognized 3Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:Respected Chiropractor Opens Office in Signal Hill/Cambodia Town and Joins Doctors on Liens 2
... Statistical Significance, IRVINE, Calif., Oct. 30 ... Biotech, today,announced that the Phase 3 SPARC trial ... did not meet its primary,efficacy endpoint. "We ... for,satraplatin did not achieve statistical significance. Drug development ...
... of radiotherapy to treat breast cancer may, in some ... potentially toxic radiation as does the standard six weeks ... That because the short treatment, known as partial breast ... breast through multiple beams, these beams can pass through ...
... SGXP ) announced today that the company will ... Grey, president & chief,executive officer of SGX Pharmaceuticals, will ... conference information is as,follows: -- BIOCOM Investor Conference ... at 9:00 AM Pacific Daylight Time at the Marriott ...
... On Sunday, November 4,2007, Eli Lilly and Company ... with,the investment community and media to review the details ... Association,Scientific Sessions in Orlando, Florida. This call will follow ... TRITON TIMI-38 trial. The Lilly conference call will ...
... Higher Volumes, ALISO VIEJO, Calif., Oct. 30 ... technology and services resource for,pathologists, oncologists and the ... quarter ended September 30, 2007. Revenue,from continuing operations ... 2007,an increase of 52 percent compared to $7.9 ...
... 2007 4:30 p.m. EST http://www.nucryst.com , WAKEFIELD, ... a webcast at 4:30 p.m. EST on Wednesday, November ... In addition to standard disclosure over wire services, a ... NUCRYST web site. To listen,to the call live on ...
Cached Medicine News:Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 2Health News:GPC Biotech Today Announced Results of Survival Analysis from the SPARC Trial 3Health News:Normal tissue not spared in new forms of breast cancer radiotherapy 2Health News:SGX Pharmaceuticals to Present at Three Upcoming Investor Conferences 2Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 2Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 3Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 4Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 5Health News:Clarient Generates 52% Revenue Increase in Third Quarter 2007 6
(Date:7/6/2015)... Increase in R&D activities ... in Germany through 2020   ... report, " Germany Bioinformatics Market Forecast & Opportunities, 2020 ... is projected to register a CAGR of over 29% ... growth on account of rising government funding and initiatives, ...
(Date:7/6/2015)... -- Cardinal Health today announced the completion of the ... generic pharmaceuticals, over-the-counter medications and related products to retail, ... Court Square Capital Partners. The $1.115 billion acquisition was ... Headquartered in Livonia, Mich. ... approximately $450 million in 2014. There are 450 employees ...
(Date:7/6/2015)... , June 29, 2015 ... addition of the "Pharmaceutical Grade Sodium Chloride Market ... to 2019" report to their offering. ... witness a CAGR of 6.9% between 2014 and 2019 ... to reach 690 KT by 2019. The ...
Breaking Medicine Technology:Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 2Germany Bioinformatics Market to Grow at a CAGR Over 29% Through 2020 Says TechSci Research 3Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... Dec. 5, 2011 The National Foundation for Infectious ... Prevention (CDC) in highlighting the importance of influenza prevention ... 10, and encouraging vaccination through the holiday season and ... steadily increased over the past few years, but many ...
... TRAB), a manufacturer and distributor of homeopathic nasal sprays for ... and migraine headaches, today announced the relocation of its corporate ... located at 4400 Route 9 South in Manalapan, New Jersey ... for the Company,s future growth. Kelly Hickel, ...
Cached Medicine Technology:National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 2National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 3National Foundation for Infectious Diseases Supports 2011 National Influenza Vaccination Week 4TheraBiogen, Inc. Relocates Corporate Headquarters to New Jersey 2
... Humphrey Field Analyzer II-i series is a ... the patient's visual field. By using SitaTM, ... is reduced by up to 70%. A ... ergonomic design to increase patient comfort while ...
... Made Toric soft contact lenses let you enjoy ... soft toric lens in a lens custom made ... comfort is made possible by PC Technology™, which ... (PC), a substance found naturally in human cell ...
Frequency 55 Toric XR is a great option for those with high levels of astigmatism...
A low water content prism-ballasted toric soft lens manufactured using patented Toric Generating lathe-cutting technology and designed for use in the correction of astigmatism on a daily wear basis....
Medicine Products: